← 產業報告目錄

Near-infrared Imaging Market by Product (Imaging System, Probe, Dye (Organic, Nanoparticle)), Procedure (Cancer, Cardio, GI, OBGYN), Application (Preclinical, Clinical, Medical), End User (Hospital, Pharma, Research Lab) & Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-08-30頁數 289報告編號 MD4138

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global near IR imaging market is projected to reach USD 1.99 billion by 2030 from USD 1.28 billion in 2025, at a CAGR of 9.3% during the forecast period. The adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging, technological advancements in near-infrared imaging modalities, and the increasing number of surgical procedures globally are major factors anticipated to boost market growth in the forecasting years. Additionally, the advantages of near-infrared imaging over conventional visualization methods also pose as a factor that contributes enormously to the increase in demand for near-infrared imaging. By procedure, the gastrointestinal surgeries segment accounted for the largest share of the market in 2024. Based on procedure, the near-infrared imaging market is segmented into gastrointestinal surgeries, plastic/reconstructive surgeries, cancer surgeries, obstetrics & gynecology surgeries, cardiovascular surgeries, and other procedures. The gastrointestinal surgeries segment is further segmented into colorectal surgeries and other gastrointestinal surgeries. The rising incidence of gastrointestinal diseases such as colorectal cancer, Crohn’s disease, ulcerative colitis, and gastric tumors significantly increases the need for surgical interventions, which is expected to fuel the demand for columns in the studied period. By application, the clinical imaging segment accounted for the largest market share in 2024. By application, the market is segmented into medical imaging, preclinical imaging, and clinical imaging. The clinical imaging segment accounted for the largest share of the market in 2024. The growth of this segment can be attributed to the increasing adoption of this imaging modality owing to the advantages offered by this technique and advancements in fluorescence imaging for clinical applications. The Asia Pacific region is expected to register the highest growth rate during the forecast period. By region, the near-infrared imaging market covers North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is estimated to register the highest growth rate during the forecast period. The presence of a large patient population, a rising geriatric population, and a huge population base for cancer and cardiovascular disease will fuel growth in this region during the forecast period. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1– 48%, Tier 2– 36%, and Tier 3– 16% • By Designation: Directors– 14%, C-level– 10%, and Others– 76% • By Region: North America– 40%, Europe– 32%, Asia Pacific– 20%, Latin America- 5%, Middle East & Africa- 3% The prominent players in the near infrared imaging market are Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Shimadzu Corporation (Japan), PerkinElmer, Inc. (US), LI-COR Biotech (US), Hamamatsu Photonics K.K. (Japan), Quest Medical Imaging B.V. (Netherlands), Merck KGaA (Germany), MIZUHO Corporation (Japan), Teledyne Princeton Instruments (US), Thermo Fisher Scientific Inc. (US), FLUOPTICS SAS (Getinge, France), Medtronic (Ireland), Cayman Chemical (US), MP Biomedicals (US), Crysta-LYN Chemical Company (US), and Gowerlabs Ltd. (UK), among others. Research Coverage This report studies the near-infrared imaging market based on product, procedure, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions). Reasons to Buy the Report The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to gain a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence. This report provides insights on the following pointers: • Analysis of key drivers (Increasing number of surgical procedures globally, advantages of near-infrared imaging over conventional visualization methods, technological advancements in near-infrared imaging modalities, adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging), restraints (Lengthy approval process for near-infrared fluorophores, high initial capital and operational costs of near-infrared systems, availability of alternate technologies), opportunities (Growth potential in emerging economies, use of blockchain for distribution and storage of medical images), and challenges (Hospital budget cuts, dearth of trained professionals in emerging economies) influencing the growth of the near infrared imaging market • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the near-infrared imaging market • Analytical Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and developments in the near-infrared imaging market • Market Development: Comprehensive information on lucrative emerging regions • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the near-infrared imaging market • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and services of the leading market players
目錄 Table of Contents
1 INTRODUCTION 28 1.1 STUDY OBJECTIVES 28 1.2 MARKET DEFINITION 28 1.3 STUDY SCOPE 29 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 29 1.3.2 INCLUSIONS & EXCLUSIONS 30 1.3.3 YEARS CONSIDERED 31 1.4 CURRENCY CONSIDERED 31 1.5 MARKET STAKEHOLDERS 32 1.6 SUMMARY OF CHANGES 32 2 RESEARCH METHODOLOGY 34 2.1 RESEARCH DATA SOURCES 34 2.1.1 SECONDARY DATA 35 2.1.1.1 List of secondary sources 35 2.1.2 PRIMARY DATA SOURCES 36 2.1.2.1 List of key primary stakeholders interviewed 36 2.1.2.2 Insights from primary experts 37 2.2 MARKET ESTIMATION METHODOLOGY 39 2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH 40 2.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 41 2.3 MARKET FORECASTING 42 2.4 PRIMARY RESEARCH VALIDATION 43 2.5 DATA TRIANGULATION & MARKET BREAKDOWN 44 2.6 RESEARCH ASSUMPTIONS 45 2.6.1 STUDY ASSUMPTIONS 45 2.7 RESEARCH LIMITATIONS 45 2.8 RISK ASSESSMENT 46 3 EXECUTIVE SUMMARY 47 4 PREMIUM INSIGHTS 52 4.1 NEAR-INFRARED IMAGING MARKET OVERVIEW 52 4.2 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT AND COUNTRY (2024) 53 4.3 NEAR-INFRARED IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54 4.4 NEAR-INFRARED IMAGING MARKET: REGIONAL MIX, 2023–2030 (USD MILLION) 55   5 MARKET OVERVIEW 56 5.1 INTRODUCTION 56 5.2 MARKET DYNAMICS 56 5.2.1 DRIVERS 57 5.2.1.1 Increasing number of surgical procedures globally 57 5.2.1.2 Advantages of near-infrared imaging over conventional visualization methods 58 5.2.1.3 Technological advancements in near-infrared imaging modalities 58 5.2.1.4 Adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging 59 5.2.2 RESTRAINTS 59 5.2.2.1 Lengthy approval process of near-infrared fluorophores 59 5.2.2.2 High initial capital and operational costs of near-infrared systems 60 5.2.2.3 Availability of alternate technologies 60 5.2.3 OPPORTUNITIES 60 5.2.3.1 Growth potential for major players in emerging economies 60 5.2.3.2 Use of blockchain for distribution and storage of medical images 61 5.2.4 CHALLENGES 61 5.2.4.1 Hospital budget cuts 61 5.2.4.2 Dearth of trained professionals in emerging economies 62 5.3 REGULATORY ANALYSIS 63 5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63 5.3.2 REGULATORY LANDSCAPE 65 5.3.2.1 North America 65 5.3.2.1.1 US 65 5.3.2.1.2 Canada 67 5.3.2.2 Europe 67 5.3.2.3 Asia Pacific 68 5.3.2.3.1 Japan 68 5.3.2.3.2 China 69 5.3.2.3.3 India 70 5.3.2.4 Middle East (GCC Region) 70 5.3.2.4.1 UAE 70 5.3.2.4.2 Saudi Arabia 70 5.3.2.5 Africa 71 5.4 REIMBURSEMENT ANALYSIS 71 5.5 VALUE CHAIN ANALYSIS 72 5.5.1 RESEARCH & DEVELOPMENT 72 5.5.2 PROCUREMENT & PRODUCT DEVELOPMENT 72 5.5.3 MARKETING, SALES, AND DISTRIBUTION 72   5.6 SUPPLY CHAIN ANALYSIS 73 5.6.1 PROMINENT COMPANIES 73 5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES 73 5.6.3 END USERS 74 5.7 ECOSYSTEM ANALYSIS 74 5.8 PORTER’S FIVE FORCES ANALYSIS 76 5.8.1 INTENSITY OF COMPETITIVE RIVALRY 77 5.8.2 BARGAINING POWER OF SUPPLIERS 77 5.8.3 BARGAINING POWER OF BUYERS 77 5.8.4 THREAT OF SUBSTITUTES 77 5.8.5 THREAT OF NEW ENTRANTS 78 5.9 KEY STAKEHOLDERS & BUYING CRITERIA 78 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS 78 5.9.2 KEY BUYING CRITERIA 79 5.10 TRADE ANALYSIS 80 5.10.1 IMPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750) 80 5.10.2 EXPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750) 81 5.11 PATENT ANALYSIS 82 5.12 PRICING ANALYSIS 85 5.12.1 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY TYPE 85 5.12.2 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY KEY PLAYER 86 5.12.3 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY REGION 87 5.13 TECHNOLOGY ANALYSIS 89 5.13.1 KEY TECHNOLOGIES 89 5.13.1.1 InGaAs (Indium Gallium Arsenide) detectors 89 5.13.1.2 CMOS sensors 90 5.13.1.3 Hyperspectral imaging 90 5.13.2 COMPLEMENTARY TECHNOLOGIES 90 5.13.2.1 Image processing software 90 5.13.2.2 Optical coherence tomography (OCT) 90 5.13.2.3 Raman spectroscopy 91 5.13.3 ADJACENT TECHNOLOGIES 91 5.13.3.1 SWIR (short-wave infrared) imaging 91 5.13.3.2 Thermal imaging 91 5.13.3.3 UV-VIS-NIR spectroscopy 91 5.14 CASE STUDY ANALYSIS 92 5.14.1 TECHNOLOGICAL CHALLENGES 92 5.14.2 LOWERING DEPENDENCE ON CONTRACT MANUFACTURING 93 5.15 KEY CONFERENCES & EVENTS, 2025–2026 93   5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94 5.17 INVESTMENT & FUNDING SCENARIO 95 5.18 UNMET NEEDS ANALYSIS 96 5.19 IMPACT OF GENERATIVE AI ON NEAR-INFRARED IMAGING MARKET 97 5.20 IMPACT OF 2025 US TARIFFS ON NEAR-INFRARED IMAGING MARKET 98 5.20.1 KEY TARIFF RATES 99 5.20.2 PRICE IMPACT ANALYSIS 100 5.20.3 PRICE IMPACT ON COUNTRY/REGION 100 5.20.3.1 US 100 5.20.3.2 Europe 101 5.20.3.3 Asia Pacific 101 5.20.4 IMPACT ON COUNTRY/REGION 101 5.20.4.1 US 101 5.20.4.2 Europe 101 5.20.4.3 Asia Pacific 102 5.20.5 IMPACT ON END-USE INDUSTRIES 102 6 NEAR-INFRARED IMAGING MARKET, BY PRODUCT 103 6.1 INTRODUCTION 104 6.2 DEVICES 104 6.2.1 FLUORESCENCE IMAGING SYSTEMS 107 6.2.1.1 Higher sensitivity and better real-time image guidance during surgeries to drive market 107 6.2.2 FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS 108 6.2.2.1 Better sensitivity and higher efficiency at lower costs to drive market 108 6.3 AGENTS/PROBES 109 6.3.1 INDOCYANINE GREEN 112 6.3.1.1 Increasing utilization of small organic probes in near-infrared imaging to drive segmental growth 112 6.3.2 OTHER REAGENTS 113 6.4 DYES 113 6.4.1 ORGANIC DYES 116 6.4.1.1 Unique molecular structure and better compatibility with biological systems to support market growth 116 6.4.2 NANOPARTICLE DYES 117 6.4.2.1 Better brightness and enhanced signal intensity compared to organic dyes to boost adoption 117 7 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE 118 7.1 INTRODUCTION 119 7.2 CANCER SURGERIES 119 7.2.1 BRAIN CANCER/TUMOR SURGERIES 121 7.2.1.1 Advancements in surgical navigation using NIR-I/II fluorescence imaging to drive market growth 121 7.2.2 OTHER CANCER SURGERIES 122 7.3 GASTROINTESTINAL SURGERIES 122 7.3.1 COLORECTAL SURGERIES 124 7.3.1.1 Advancements in treatment strategies and procedures to support market growth 124 7.3.2 OTHER GASTROINTESTINAL SURGERIES 125 7.4 CARDIOVASCULAR SURGERIES 126 7.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES AMONG ALL AGE GROUPS TO DRIVE MARKET GROWTH 126 7.5 PLASTIC/RECONSTRUCTIVE SURGERIES 127 7.5.1 RISING NUMBER OF RECONSTRUCTIVE SURGERIES GLOBALLY TO BOOST MARKET 127 7.6 OBSTETRICS & GYNECOLOGY SURGERIES 129 7.6.1 INCREASED NUMBER OF CLINICAL TRIALS AND IMPROVED TISSUE CONTRAST DURING SURGERIES TO CONTRIBUTE TO GROWTH 129 7.7 OTHER PROCEDURES 130 8 NEAR-INFRARED IMAGING MARKET, BY APPLICATION 131 8.1 INTRODUCTION 132 8.2 PRECLINICAL IMAGING 132 8.2.1 GROWING FOCUS ON DEVELOPING NEW TREATMENTS FOR CHRONIC DISEASES TO DRIVE MARKET 132 8.3 CLINICAL IMAGING 133 8.3.1 INCREASING USE OF NEAR-INFRARED IMAGING FOR REAL-TIME VISUALIZATION DURING SURGERIES TO FUEL GROWTH 133 8.4 MEDICAL IMAGING 134 8.4.1 GROWING APPLICATIONS OF FLUORESCENCE IMAGING SINGLE-CELL TRACKING FOR STUDYING IMMUNE SYSTEM TO DRIVE MARKET 134 9 NEAR-INFRARED IMAGING MARKET, BY END USER 136 9.1 INTRODUCTION 137 9.2 HOSPITALS & SURGICAL CLINICS 137 9.2.1 RISING NUMBER OF CANCER AND RECONSTRUCTIVE SURGERIES TO DRIVE MARKET GROWTH 137 9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 138 9.3.1 GROWING PRECLINICAL RESEARCH AND DRUG DISCOVERY TO BOOST GROWTH 138 9.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES 139 9.4.1 FUNDING FROM GOVERNMENT ORGANIZATIONS FOR BIOMEDICAL RESEARCH TO SUPPORT MARKET GROWTH 139 9.5 OTHER END USERS 141   10 NEAR-INFRARED IMAGING MARKET, BY REGION 142 10.1 INTRODUCTION 143 10.2 NORTH AMERICA 143 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 143 10.2.2 US 148 10.2.2.1 Advanced healthcare infrastructure and favorable regulations to drive market 148 10.2.3 CANADA 150 10.2.3.1 Increased availability of research funding to drive market 150 10.3 EUROPE 152 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 152 10.3.2 GERMANY 157 10.3.2.1 Increasing healthcare expenditure and government spending to drive market growth 157 10.3.3 FRANCE 159 10.3.3.1 Increasing target patient population and rising number of diagnostic tests for chronic diseases to boost market 159 10.3.4 UK 161 10.3.4.1 Growing government initiatives and increasing incidence of chronic diseases to support growth 161 10.3.5 ITALY 164 10.3.5.1 Increased availability of reimbursement coverage for diagnostic procedures to fuel growth 164 10.3.6 SPAIN 165 10.3.6.1 Increasing prevalence of cancer and growing private-public funding to propel growth 165 10.3.7 REST OF EUROPE 167 10.4 ASIA PACIFIC 169 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 169 10.4.2 CHINA 175 10.4.2.1 Increasing healthcare reforms and government investments to drive market 175 10.4.3 JAPAN 177 10.4.3.1 Fast adoption of advanced technologies and growth in geriatric population to boost market 177 10.4.4 INDIA 179 10.4.4.1 Increasing number of diagnostic procedures and improving healthcare infrastructure to drive market 179 10.4.5 AUSTRALIA 181 10.4.5.1 Growing healthcare spending and increasing investments in research to fuel growth 181 10.4.6 SOUTH KOREA 183 10.4.6.1 Presence of advanced healthcare system and increased awareness about diseases to contribute to growth 183 10.4.7 REST OF ASIA PACIFIC 185 10.5 LATIN AMERICA 187 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 187 10.5.2 BRAZIL 192 10.5.2.1 Greater purchasing power and more favorable demographic conditions to boost growth 192 10.5.3 MEXICO 193 10.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market 193 10.5.4 REST OF LATIN AMERICA 195 10.6 MIDDLE EAST & AFRICA 197 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 197 10.6.2 GCC COUNTRIES 202 10.6.2.1 Supportive government initiatives to aid market growth 202 10.6.3 REST OF MIDDLE EAST & AFRICA 204 11 COMPETITIVE LANDSCAPE 206 11.1 OVERVIEW 206 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 206 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NEAR-INFRARED IMAGING MARKET 206 11.3 REVENUE ANALYSIS, 2020−2024 208 11.4 MARKET SHARE ANALYSIS, 2024 208 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 210 11.5.1 STARS 210 11.5.2 EMERGING LEADERS 211 11.5.3 PERVASIVE PLAYERS 211 11.5.4 PARTICIPANTS 211 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 213 11.5.5.1 Company footprint 213 11.5.5.2 Region footprint 214 11.5.5.3 Product footprint 215 11.5.5.4 Procedure footprint 216 11.5.5.5 Application footprint 217 11.5.5.6 End-user footprint 218 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 219 11.6.1 PROGRESSIVE COMPANIES 219 11.6.2 RESPONSIVE COMPANIES 219 11.6.3 DYNAMIC COMPANIES 219 11.6.4 STARTING BLOCKS 219 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 221 11.6.5.1 Detailed list of key startups/SMEs 221 11.6.5.2 Competitive benchmarking of key emerging players/startups 222   11.7 COMPANY VALUATION & FINANCIAL METRICS 223 11.7.1 FINANCIAL METRICS 223 11.7.2 COMPANY VALUATION 223 11.8 BRAND/PRODUCT COMPARISON 224 11.9 COMPETITIVE SCENARIO 225 11.9.1 PRODUCT LAUNCHES 225 11.9.2 DEALS 226 11.9.3 EXPANSIONS 227 12 COMPANY PROFILES 228 12.1 KEY PLAYERS 228 12.1.1 STRYKER 228 12.1.1.1 Business overview 228 12.1.1.2 Products offered 229 12.1.1.3 Recent developments 230 12.1.1.3.1 Product launches 230 12.1.1.3.2 Deals 231 12.1.1.4 MnM view 231 12.1.1.4.1 Right to win 231 12.1.1.4.2 Strategic choices 231 12.1.1.4.3 Weaknesses & competitive threats 231 12.1.2 CARL ZEISS MEDITEC AG 232 12.1.2.1 Business overview 232 12.1.2.2 Products offered 233 12.1.2.3 Recent developments 234 12.1.2.3.1 Product launches 234 12.1.2.3.2 Deals 234 12.1.2.3.3 Expansions 234 12.1.2.4 MnM view 235 12.1.2.4.1 Right to win 235 12.1.2.4.2 Strategic choices 235 12.1.2.4.3 Weaknesses & competitive threats 235 12.1.3 PERKINELMER, INC. 236 12.1.3.1 Business overview 236 12.1.3.2 Products offered 236 12.1.3.3 Recent developments 237 12.1.3.3.1 Expansions 237 12.1.4 OLYMPUS CORPORATION 238 12.1.4.1 Business overview 238 12.1.4.2 Products offered 239 12.1.4.3 Recent developments 240 12.1.4.3.1 Product launches 240 12.1.4.3.2 Deals 240 12.1.4.3.3 Expansions 240 12.1.4.4 MnM view 241 12.1.4.4.1 Right to win 241 12.1.4.4.2 Strategic choices 241 12.1.4.4.3 Weaknesses & competitive threats 241 12.1.5 LEICA MICROSYSTEMS 242 12.1.5.1 Business overview 242 12.1.5.2 Products offered 243 12.1.5.3 Recent developments 244 12.1.5.3.1 Deals 244 12.1.5.3.2 Expansions 244 12.1.5.4 MnM view 244 12.1.5.4.1 Right to win 244 12.1.5.4.2 Strategic choices 244 12.1.5.4.3 Weaknesses & competitive threats 245 12.1.6 KARL STORZ SE & CO. KG 246 12.1.6.1 Business overview 246 12.1.6.2 Products offered 246 12.1.6.3 MnM view 247 12.1.6.3.1 Right to win 247 12.1.6.3.2 Strategic choices 247 12.1.6.3.3 Weaknesses & competitive threats 247 12.1.7 SHIMADZU CORPORATION 248 12.1.7.1 Business overview 248 12.1.7.2 Products offered 249 12.1.7.3 Recent developments 250 12.1.7.3.1 Product launches 250 12.1.7.3.2 Deals 250 12.1.7.3.3 Expansions 250 12.1.8 LI-COR BIOTECH, LLC 251 12.1.8.1 Business overview 251 12.1.8.2 Products offered 251 12.1.8.3 Recent developments 252 12.1.8.3.1 Product launches 252 12.1.9 HAMAMATSU PHOTONICS K.K. 253 12.1.9.1 Business overview 253 12.1.9.2 Products offered 254 12.1.9.3 Recent developments 255 12.1.9.3.1 Expansions 255   12.1.10 QUEST MEDICAL IMAGING B.V. 256 12.1.10.1 Business overview 256 12.1.10.2 Products offered 256 12.1.11 MERCK KGAA (SIGMA-ALDRICH) 257 12.1.11.1 Business overview 257 12.1.11.2 Products offered 258 12.1.11.3 Recent developments 259 12.1.11.3.1 Expansions 259 12.1.12 MIZUHO MEDICAL CO., LTD. 260 12.1.12.1 Business overview 260 12.1.12.2 Products offered 260 12.1.13 TELEDYNE PRINCETON INSTRUMENTS 261 12.1.13.1 Business overview 261 12.1.13.2 Products offered 262 12.1.14 THERMO FISHER SCIENTIFIC INC. 263 12.1.14.1 Business overview 263 12.1.14.2 Products offered 264 12.1.15 FLUOPTICS SAS (PART OF GETINGE) 265 12.1.15.1 Business overview 265 12.1.15.2 Products offered 265 12.1.16 MEDTRONIC 266 12.1.16.1 Business overview 266 12.1.16.2 Products offered 266 12.1.17 CAYMAN CHEMICAL 267 12.1.17.1 Business overview 267 12.1.17.2 Products offered 267 12.1.18 MP BIOMEDICALS 268 12.1.18.1 Business overview 268 12.1.18.2 Products offered 268 12.1.19 CRYSTA-LYN CHEMICAL COMPANY 269 12.1.19.1 Business overview 269 12.1.19.2 Products offered 269 12.1.20 GOWERLABS LTD. 270 12.1.20.1 Business overview 270 12.1.20.2 Products offered 270 12.2 OTHER PLAYERS 271 12.2.1 NIRX MEDICAL TECHNOLOGIES, LLC 271 12.2.2 EXOSENS (XENICS NV) 272 12.2.3 BIOTIUM 273 12.2.4 TOKYO CHEMICAL INDUSTRY (INDIA) PVT. LTD. 274 12.2.5 AAT BIOQUEST, INC. 275 12.2.6 OXFORD INSTRUMENTS 276 12.2.7 MOTHERSON 277 12.2.8 PHOTON ETC 278 12.2.9 SOTERIX MEDICAL INC. 279 12.2.10 KERNEL 280 13 APPENDIX 281 13.1 DISCUSSION GUIDE 281 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 285 13.3 CUSTOMIZATION OPTIONS 287 13.4 RELATED REPORTS 287 13.5 AUTHOR DETAILS 288
圖表清單 List of Tables & Figures
TABLE 1 ADVANTAGES OF NEAR-INFRARED IMAGING OVER CONVENTIONAL VISUALIZATION METHODS 58 TABLE 2 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63 TABLE 3 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63 TABLE 4 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 TABLE 5 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 TABLE 6 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65 TABLE 7 US: APPROVED IMAGING DEVICES BY FDA 65 TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION 66 TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 66 TABLE 10 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67 TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 68 TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 69 TABLE 13 MEDICAL REIMBURSEMENT CPT CODES FOR NEAR-INFRARED PROCEDURES IN US (2025) 71 TABLE 14 NEAR-INFRARED IMAGING MARKET: ROLE IN ECOSYSTEM 75 TABLE 15 NEAR-INFRARED IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 76 TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEAR-INFRARED IMAGING PRODUCTS 79 TABLE 17 KEY BUYING CRITERIA FOR NEAR-INFRARED IMAGING PRODUCTS 79 TABLE 18 IMPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750), BY COUNTRY, 2020−2024 (USD) 80 TABLE 19 EXPORT DATA FOR NEAR-INFRARED IMAGING PRODUCTS (HS CODE 902750), BY COUNTRY, 2020−2024 (USD) 81 TABLE 20 AVERAGE SELLING PRICE OF TOP NIR PRODUCTS, BY KEY PLAYER, 2024 (USD) 86 TABLE 21 AVERAGE SELLING PRICE TREND OF NEAR-INFRARED IMAGING PRODUCTS, BY REGION, 2022–2024 87 TABLE 22 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE 92 TABLE 23 CASE STUDY 2: PROVIDING TRAINING AND EDUCATION AND KEEPING UP WITH EVOLVING SURGICAL TECHNIQUES 93 TABLE 24 NEAR-INFRARED IMAGING MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS 93 TABLE 25 NEAR-INFRARED IMAGING MARKET: CURRENT UNMET NEEDS 96 TABLE 26 US-ADJUSTED RECIPROCAL TARIFF RATES (AS OF AUGUST, 2025) 99 TABLE 27 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 104 TABLE 28 NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 104 TABLE 29 NEAR-INFRARED IMAGING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 105 TABLE 30 NEAR-INFRARED IMAGING DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 105 TABLE 31 NEAR-INFRARED IMAGING DEVICES MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 106 TABLE 32 NEAR-INFRARED IMAGING DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 106 TABLE 33 NEAR-INFRARED IMAGING DEVICES MARKET FOR FLUORESCENCE IMAGING SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 108 TABLE 34 NEAR-INFRARED IMAGING DEVICES MARKET FOR FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 35 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 110 TABLE 36 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 37 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 110 TABLE 38 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 111 TABLE 39 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY END USER, 2023–2030 (USD MILLION) 111 TABLE 40 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET FOR INDOCYANINE GREEN, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 41 NEAR-INFRARED IMAGING AGENTS/PROBES MARKET FOR OTHER REAGENTS, BY REGION, 2023–2030 (USD MILLION) 113 TABLE 42 NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 114 TABLE 43 NEAR-INFRARED IMAGING DYES MARKET, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 44 NEAR-INFRARED IMAGING DYES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 114 TABLE 45 NEAR-INFRARED IMAGING DYES MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 115 TABLE 46 NEAR-INFRARED IMAGING DYES MARKET, BY END USER, 2023–2030 (USD MILLION) 115 TABLE 47 NEAR-INFRARED IMAGING DYES MARKET FOR ORGANIC DYES, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 48 NEAR-INFRARED IMAGING DYES MARKET FOR NANOPARTICLE DYES, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 49 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 119 TABLE 50 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 120 TABLE 51 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 52 NEAR-INFRARED IMAGING MARKET FOR BRAIN CANCER/TUMOR SURGERIES, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 53 NEAR-INFRARED IMAGING MARKET FOR OTHER CANCER SURGERIES, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 54 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 123 TABLE 55 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 56 NEAR-INFRARED IMAGING MARKET FOR COLORECTAL SURGERIES, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 57 NEAR-INFRARED IMAGING MARKET FOR OTHER GASTROINTESTINAL SURGERIES, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 58 NEAR-INFRARED IMAGING MARKET FOR CARDIOVASCULAR SURGERIES, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 59 NEAR-INFRARED IMAGING MARKET FOR PLASTIC/RECONSTRUCTIVE SURGERIES, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 60 NEAR-INFRARED IMAGING MARKET FOR OBSTETRICS & GYNECOLOGY SURGERIES, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 61 NEAR-INFRARED IMAGING MARKET FOR OTHER PROCEDURES, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 62 NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 132 TABLE 63 NEAR-INFRARED IMAGING MARKET FOR PRECLINICAL IMAGING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 64 NEAR-INFRARED IMAGING MARKET FOR CLINICAL IMAGING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 65 NEAR-INFRARED IMAGING MARKET FOR MEDICAL IMAGING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 66 NEAR-INFRARED IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 137 TABLE 67 NEAR-INFRARED IMAGING MARKET FOR HOSPITALS & SURGICAL CLINICS, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 68 NEAR-INFRARED IMAGING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 69 NEAR-INFRARED IMAGING MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 70 NEAR-INFRARED IMAGING MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 71 NEAR-INFRARED IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 72 NORTH AMERICA: KEY MACROINDICATORS 144 TABLE 73 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 74 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 145 TABLE 75 NORTH AMERICA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 76 NORTH AMERICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 77 NORTH AMERICA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 78 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 147 TABLE 79 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 147 TABLE 80 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 148 TABLE 81 US: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 149 TABLE 82 US: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 83 US: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 84 US: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 85 CANADA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 151 TABLE 86 CANADA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 151 TABLE 87 CANADA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 152 TABLE 88 CANADA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 152 TABLE 89 EUROPE: KEY MACROINDICATORS 153 TABLE 90 EUROPE: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 91 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 154 TABLE 92 EUROPE: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 93 EUROPE: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 94 EUROPE: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 155 TABLE 95 EUROPE: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 155 TABLE 96 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 156 TABLE 97 EUROPE: NEAR-INFRARED IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 156 TABLE 98 GERMANY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 157 TABLE 99 GERMANY: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 100 GERMANY: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 101 GERMANY: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 102 FRANCE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 159 TABLE 103 FRANCE: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 104 FRANCE: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 105 FRANCE: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 106 UK: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 161 TABLE 107 UK: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 108 UK: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 109 UK: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 110 UK: NUMBER OF FLUOROSCOPY IMAGING ACTIVITIES, 2012–2024 163 TABLE 111 ITALY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 164 TABLE 112 ITALY: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 113 ITALY: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 114 ITALY: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 115 SPAIN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 166 TABLE 116 SPAIN: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 117 SPAIN: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 118 SPAIN: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 119 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 168 TABLE 120 REST OF EUROPE: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 121 REST OF EUROPE: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 122 REST OF EUROPE: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 123 ASIA PACIFIC: MACROECONOMIC INDICATORS 170 TABLE 124 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 125 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 172 TABLE 126 ASIA PACIFIC: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 127 ASIA PACIFIC: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 128 ASIA PACIFIC: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 129 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 174 TABLE 130 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 174 TABLE 131 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 175 TABLE 132 CHINA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 176 TABLE 133 CHINA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 134 CHINA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 135 CHINA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 136 JAPAN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 178 TABLE 137 JAPAN: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 138 JAPAN: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 139 JAPAN: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 140 INDIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 180 TABLE 141 INDIA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 142 INDIA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 143 INDIA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 144 AUSTRALIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 182 TABLE 145 AUSTRALIA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 146 AUSTRALIA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 147 AUSTRALIA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 148 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 184 TABLE 149 SOUTH KOREA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 150 SOUTH KOREA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 151 SOUTH KOREA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 152 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 186 TABLE 153 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 154 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 155 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 156 LATIN AMERICA: KEY MACROINDICATORS 188 TABLE 157 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 158 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 189 TABLE 159 LATIN AMERICA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 160 LATIN AMERICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 161 LATIN AMERICA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 162 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 190 TABLE 163 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 191 TABLE 164 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 191 TABLE 165 BRAZIL: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 192 TABLE 166 BRAZIL: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 167 BRAZIL: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 168 BRAZIL: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 169 MEXICO: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 194 TABLE 170 MEXICO: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 171 MEXICO: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 172 MEXICO: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 173 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 196 TABLE 174 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 175 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 176 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 177 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 198 TABLE 178 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION) 198 TABLE 179 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 199 TABLE 180 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 181 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 182 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 183 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 200 TABLE 184 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 201 TABLE 185 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 201 TABLE 186 GCC COUNTRIES: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 202 TABLE 187 GCC COUNTRIES: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 188 GCC COUNTRIES: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 189 GCC COUNTRIES: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 190 REST OF MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 204 TABLE 191 REST OF MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 192 REST OF MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING AGENTS/PROBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 193 REST OF MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING DYES MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 194 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN NEAR-INFRARED IMAGING MARKET 206 TABLE 195 NEAR-INFRARED IMAGING MARKET: DEGREE OF COMPETITION 209 TABLE 196 NEAR-INFRARED IMAGING MARKET: REGION FOOTPRINT 214 TABLE 197 NEAR-INFRARED IMAGING MARKET: PRODUCT FOOTPRINT 215 TABLE 198 NEAR-INFRARED IMAGING MARKET: PROCEDURE FOOTPRINT 216 TABLE 199 NEAR-INFRARED IMAGING MARKET: APPLICATION FOOTPRINT 217 TABLE 200 NEAR-INFRARED IMAGING MARKET: END-USER FOOTPRINT 218 TABLE 201 NEAR-INFRARED IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 221 TABLE 202 NEAR-INFRARED IMAGING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 222 TABLE 203 NEAR-INFRARED IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 225 TABLE 204 NEAR-INFRARED IMAGING MARKET: DEALS, JANUARY 2021–JULY 2025 226 TABLE 205 NEAR-INFRARED IMAGING MARKET: EXPANSIONS, JANUARY 2021–JULY 2025 227 TABLE 206 STRYKER: COMPANY OVERVIEW 228 TABLE 207 STRYKER: PRODUCTS OFFERED 229 TABLE 208 STRYKER: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 230 TABLE 209 STRYKER: DEALS, JANUARY 2021–JULY 2025 231 TABLE 210 CARL ZEISS MEDITEC GROUP: COMPANY OVERVIEW 232 TABLE 211 CARL ZEISS MEDITEC GROUP: PRODUCTS OFFERED 233 TABLE 212 CARL ZEISS MEDITEC GROUP: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 234 TABLE 213 CARL ZEISS MEDITEC GROUP: DEALS, JANUARY 2021–JULY 2025 234 TABLE 214 CARL ZEISS MEDITEC GROUP: EXPANSIONS, JANUARY 2021–JULY 2025 234 TABLE 215 PERKINELMER, INC.: COMPANY OVERVIEW 236 TABLE 216 PERKINELMER, INC.: PRODUCTS OFFERED 236 TABLE 217 PERKINELMER, INC.: EXPANSIONS, JANUARY 2021–JULY 2025 237 TABLE 218 OLYMPUS CORPORATION: COMPANY OVERVIEW 238 TABLE 219 OLYMPUS CORPORATION: PRODUCTS OFFERED 239 TABLE 220 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 240 TABLE 221 OLYMPUS CORPORATION: DEALS, JANUARY 2021–JULY 2025 240 TABLE 222 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2021–JULY 2025 240 TABLE 223 LEICA MICROSYSTEMS: COMPANY OVERVIEW 242 TABLE 224 LEICA MICROSYSTEMS: PRODUCTS OFFERED 243 TABLE 225 LEICA MICROSYSTEMS: DEALS, JANUARY 2021–JULY 2025 244 TABLE 226 LEICA MICROSYSTEMS: EXPANSIONS, JANUARY 2021–JULY 2025 244 TABLE 227 KARL STORZ SE & CO. KG: COMPANY OVERVIEW 246 TABLE 228 KARL STORZ SE & CO. KG: PRODUCTS OFFERED 246 TABLE 229 SHIMADZU CORPORATION: COMPANY OVERVIEW 248 TABLE 230 SHIMADZU CORPORATION: PRODUCTS OFFERED 249 TABLE 231 SHIMADZU CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 250 TABLE 232 SHIMADZU CORPORATION: DEALS, JANUARY 2021–JULY 2025 250 TABLE 233 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2021–JULY 2025 250 TABLE 234 LI-COR BIOTECH, LLC: COMPANY OVERVIEW 251 TABLE 235 LI-COR BIOTECH, LLC: PRODUCTS OFFERED 251 TABLE 236 LI-COR BIOTECH, LLC: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 252 TABLE 237 HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW 253 TABLE 238 HAMAMATSU PHOTONICS K.K.: PRODUCTS OFFERED 254 TABLE 239 HAMAMATSU PHOTONICS K.K.: EXPANSIONS, JANUARY 2021–JULY 2025 255 TABLE 240 QUEST MEDICAL IMAGING B.V.: COMPANY OVERVIEW 256 TABLE 241 QUEST MEDICAL IMAGING B.V.: PRODUCTS OFFERED 256 TABLE 242 MERCK KGAA: COMPANY OVERVIEW 257 TABLE 243 MERCK KGAA: PRODUCTS OFFERED 258 TABLE 244 MERCK KGAA: EXPANSIONS, JANUARY 2021–JULY 2025 259 TABLE 245 MIZUHO MEDICAL CO., LTD.: COMPANY OVERVIEW 260 TABLE 246 MIZUHO MEDICAL CO., LTD.: PRODUCTS OFFERED 260 TABLE 247 TELEDYNE PRINCETON INSTRUMENTS: COMPANY OVERVIEW 261 TABLE 248 TELEDYNE PRINCETON INSTRUMENTS: PRODUCTS OFFERED 262 TABLE 249 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 263 TABLE 250 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 264 TABLE 251 FLUOPTICS SAS: COMPANY OVERVIEW 265 TABLE 252 FLUOPTICS SAS: PRODUCTS OFFERED 265 TABLE 253 MEDTRONIC: COMPANY OVERVIEW 266 TABLE 254 MEDTRONIC: PRODUCTS OFFERED 266 TABLE 255 CAYMAN CHEMICAL: COMPANY OVERVIEW 267 TABLE 256 CAYMAN CHEMICAL: PRODUCTS OFFERED 267 TABLE 257 MP BIOMEDICALS: COMPANY OVERVIEW 268 TABLE 258 MP BIOMEDICALS: PRODUCTS OFFERED 268 TABLE 259 CRYSTA-LYN CHEMICAL COMPANY: COMPANY OVERVIEW 269 TABLE 260 CRYSTA-LYN CHEMICAL COMPANY: PRODUCTS OFFERED 269 TABLE 261 GOWERLABS LTD.: COMPANY OVERVIEW 270 TABLE 262 GOWERLABS LTD.: PRODUCTS OFFERED 270 TABLE 263 NIRX MEDICAL TECHNOLOGIES, LLC: COMPANY OVERVIEW 271 TABLE 264 EXOSENS (XENICS NV): COMPANY OVERVIEW 272 TABLE 265 BIOTIUM: COMPANY OVERVIEW 273 TABLE 266 TOKYO CHEMICAL INDUSTRY (INDIA) PVT. LTD.: COMPANY OVERVIEW 274 TABLE 267 AAT BIOQUEST, INC.: COMPANY OVERVIEW 275 TABLE 268 OXFORD INSTRUMENTS: COMPANY OVERVIEW 276 TABLE 269 MOTHERSON: COMPANY OVERVIEW 277 TABLE 270 PHOTON ETC: COMPANY OVERVIEW 278 TABLE 271 SOTERIX MEDICAL INC.: COMPANY OVERVIEW 279 TABLE 272 KERNEL: COMPANY OVERVIEW 280 FIGURE 1 NEAR-INFRARED IMAGING MARKET SEGMENTATION & REGIONAL SCOPE 29 FIGURE 2 NEAR-INFRARED IMAGING MARKET: RESEARCH DESIGN 34 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 38 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 38 FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 40 FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 41 FIGURE 7 NEAR-INFRARED IMAGING MARKET: BOTTOM-UP APPROACH 42 FIGURE 8 NEAR-INFRARED IMAGING MARKET: CAGR PROJECTIONS 43 FIGURE 9 DATA TRIANGULATION METHODOLOGY 44 FIGURE 10 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 47 FIGURE 11 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2025 VS. 2030 (USD MILLION) 48 FIGURE 12 NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 49 FIGURE 13 NEAR-INFRARED IMAGING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 50 FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NEAR-INFRARED IMAGING MARKET 51 FIGURE 15 RISING ADOPTION OF NEAR-INFRARED IMAGING IN SURGICAL AND DIAGNOSTIC APPLICATIONS DRIVING MARKET GROWTH 52 FIGURE 16 DEVICES SEGMENT HELD LARGEST SHARE OF MARKET IN 2O24 53 FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 54 FIGURE 18 NORTH AMERICA TO CONTINUE TO DOMINATE NEAR-INFRARED IMAGING MARKET DURING FORECAST PERIOD 55 FIGURE 19 NEAR-INFRARED IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56 FIGURE 20 NEAR-INFRARED IMAGING MARKET: VALUE CHAIN ANALYSIS 73 FIGURE 21 NEAR-INFRARED IMAGING MARKET: SUPPLY CHAIN ANALYSIS 74 FIGURE 22 NEAR-INFRARED IMAGING MARKET: ECOSYSTEM ANALYSIS 75 FIGURE 23 NEAR-INFRARED IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 76 FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEAR-INFRARED IMAGING PRODUCTS 78 FIGURE 25 KEY BUYING CRITERIA FOR NEAR-INFRARED IMAGING PRODUCTS 79 FIGURE 26 NEAR-INFRARED IMAGING MARKET: TOP PATENT OWNERS/PATENTING TRENDS FOR NEAR-INFRARED IMAGING IN RECENT YEARS 82 FIGURE 27 NEAR-INFRARED IMAGING MARKET: TOP PATENT OWNERS/PATENTING TRENDS FOR NEAR-INFRARED FLUORESCENCE IMAGING IN RECENT YEARS 83 FIGURE 28 NEAR-INFRARED DYES MARKET: TOP PATENT OWNERS/PATENTING TRENDS FOR NEAR-INFRARED FLUORESCENCE BIOLUMINESCENCE IMAGING IN RECENT YEARS 84 FIGURE 29 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY TYPE, 2024 (USD) 85 FIGURE 30 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY KEY PLAYER, 2024 (USD) 86 FIGURE 31 AVERAGE SELLING PRICE OF NEAR-INFRARED IMAGING PRODUCTS, BY REGION, 2024 (USD) 87 FIGURE 32 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94 FIGURE 33 NEAR-INFRARED IMAGING MARKET: NUMBER OF DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 95 FIGURE 34 NEAR-INFRARED IMAGING MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 95 FIGURE 35 VALUE OF INVESTOR DEALS IN NEAR-INFRARED IMAGING MARKET, BY KEY PLAYER, 2019–2023 (USD MILLION) 96 FIGURE 36 USE OF GEN AI IN NEAR-INFRARED IMAGING MARKET 98 FIGURE 37 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET SNAPSHOT 144 FIGURE 38 UK: NUMBER OF FLUOROSCOPY IMAGING ACTIVITIES (2023–2024) 163 FIGURE 39 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET SNAPSHOT 171 FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN NEAR-INFRARED IMAGING MARKET (2020−2024) 208 FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN NEAR-INFRARED IMAGING MARKET (2024) 209 FIGURE 42 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 212 FIGURE 43 NEAR-INFRARED IMAGING MARKET: COMPANY FOOTPRINT 213 FIGURE 44 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 220 FIGURE 45 EV/EBITDA OF KEY VENDORS 223 FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 223 FIGURE 47 NEAR-INFRARED IMAGING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 224 FIGURE 48 STRYKER: COMPANY SNAPSHOT (2024) 229 FIGURE 49 CARL ZEISS MEDITEC GROUP: COMPANY SNAPSHOT (2024) 233 FIGURE 50 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024) 239 FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 243 FIGURE 52 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024) 249 FIGURE 53 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2024) 254 FIGURE 54 MERCK KGAA: COMPANY SNAPSHOT (2024) 258 FIGURE 55 TELEDYNE PRINCETON INSTRUMENTS: COMPANY SNAPSHOT (2024) 262 FIGURE 56 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 264

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們